EDSA

Edesa Biotech Inc. (EDSA), a clinical-stage biopharmaceutical company headquartered in Markham, Canada, is focused on developing innovative therapies for inflammatory and immune-related disorders, addressing significant unmet medical needs. The company's robust pipeline showcases proprietary technologies aimed at improving treatment options in dermatological and gastrointestinal diseases, positioning Edesa at the forefront of biotherapeutics. With ongoing clinical trials and a steadfast commitment to enhancing patient outcomes, Edesa is well-positioned to make impactful contributions to the healthcare landscape as it seeks to expand its market presence.